These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25569716)

  • 1. Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.
    Nie Z; Du MQ; McAllister-Lucas LM; Lucas PC; Bailey NG; Hogaboam CM; Lim MS; Elenitoba-Johnson KS
    Nat Commun; 2015 Jan; 6():5908. PubMed ID: 25569716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.
    Izumiyama K; Nakagawa M; Yonezumi M; Kasugai Y; Suzuki R; Suzuki H; Tsuzuki S; Hosokawa Y; Asaka M; Seto M
    Oncogene; 2003 Nov; 22(50):8085-92. PubMed ID: 14603249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of API2-MALT1 fusion gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas and diffuse large B cell lymphomas].
    Li BZ; Lu HF; Sheng WQ; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):765-8. PubMed ID: 20079017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. API2-MALT1 fusion gene in colorectal lymphoma.
    Sakugawa ST; Yoshino T; Nakamura S; Inagaki H; Sadahira Y; Nakamine H; Okabe M; Ichimura K; Tanimoto M; Akagi T
    Mod Pathol; 2003 Dec; 16(12):1232-41. PubMed ID: 14681324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
    Hosokawa Y
    Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma.
    Hosokawa Y; Suzuki H; Suzuki Y; Takahashi R; Seto M
    Cancer Res; 2004 May; 64(10):3452-7. PubMed ID: 15150097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.
    Baens M; Fevery S; Sagaert X; Noels H; Hagens S; Broeckx V; Billiau AD; De Wolf-Peeters C; Marynen P
    Cancer Res; 2006 May; 66(10):5270-7. PubMed ID: 16707452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.
    Nakagawa M; Seto M; Hosokawa Y
    Leukemia; 2006 Jun; 20(6):929-36. PubMed ID: 16572204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.
    Rosebeck S; Lim MS; Elenitoba-Johnson KS; McAllister-Lucas LM; Lucas PC
    World J Biol Chem; 2016 Feb; 7(1):128-37. PubMed ID: 26981201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous copy numbers of API2-MALT1 chimeric transcripts in mucosa-associated lymphoid tissue lymphoma.
    Suguro-Katayama M; Suzuki R; Kasugai Y; Nakamura T; Suzuki H; Hosokawa Y; Shiku H; Nakamura S; Seto M
    Leukemia; 2003 Dec; 17(12):2508-12. PubMed ID: 14562112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The API2/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis.
    Stoffel A; Le Beau MM
    Hum Hered; 2001; 51(1-2):1-7. PubMed ID: 11096264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.
    Noels H; Somers R; Liu H; Ye H; Du MQ; De Wolf-Peeters C; Marynen P; Baens M
    PLoS One; 2009; 4(3):e4822. PubMed ID: 19279678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
    Okabe M; Inagaki H; Ohshima K; Yoshino T; Li C; Eimoto T; Ueda R; Nakamura S
    Am J Pathol; 2003 Apr; 162(4):1113-22. PubMed ID: 12651604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
    Nakamura T; Inagaki H; Seto M; Nakamura S
    J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The frequency of API2-MALT1 fusion gene variants in MALT lymphoma and its correlation with apoptosis of MALT lymphoma].
    Yang WX; Li GD; Zhou Q; Liu WP; Chen N; Gong J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):35-9. PubMed ID: 15696476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
    Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
    J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.
    Rosebeck S; Lucas PC; McAllister-Lucas LM
    Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The t(14;18)(q32;q21)/IGH-MALT1 translocation in gastrointestinal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
    Zhang S; Wei M; Liang Q; Johnson D; Dow N; Nelson A; Aguilera N; Auerbach A; Wang G
    Histopathology; 2014 May; 64(6):791-8. PubMed ID: 24236896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas.
    Wimberger N; Ober F; Avar G; Grau M; Xu W; Lenz G; Menden MP; Krappmann D
    Blood; 2023 Dec; 142(23):1985-2001. PubMed ID: 37623434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.